TUESDAY, April 30, 2019 -- Tagraxofusp appears effective for treating the rare aggressive hematologic cancer blastic plasmacytoid dendritic-cell neoplasm (BPDCN), according to a study published in the April 25 issue of the New England Journal of...
Original Article: Targeted Therapy Promising for Rare Hematologic Cancer